Rethink Relievers: Optimize Asthma Therapy with PRN Anti-Inflammatory Relievers
How to participate in the activity: To register for this activity, participants can click the link HERE to request a specific time and date for the academic detailing visit.
Target Audience: Pharmacists
Fee: Free
Expiration Date: February 16, 2026
Number of Credit Hours: 0.5 contact hours (0.05 CEUs)
Type of Activity: Knowledge-based
Learning Objectives:
- Describe the paradigm shift from SABA only to AIR therapies, including supporting evidence
- Description of SMART therapy with evidence, benefits, and dosing recommendations
- Identify the barriers to SMART therapy and methods to address the challenge
- Discuss AIR therapy options beyond SMART therapy
Speaker(s): For a list of potential speakers please visit Academic Detailers/Disclosures
ACPE Heading link
The University of Illinois at Chicago Retzky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Each activity has been assigned an ACPE Universal Activity Number, which grants 0.5 contact hours (0.05 CEUs) per CE course. Reading the learning objectives and faculty disclosures; participating in the entire knowledge-based activity, active learning activity, post-test, and activity evaluation; estimating the duration of time spent on the activity; and submitting NABP eProfile ID and MMDD are prerequisites for receiving continuing pharmacy education credits. All ACPE credit awarded to participants must be uploaded to CPE Monitor ™ within 30 days of the activity date, pharmacists are required to provide their eProfile ID and date of birth (MMDD) at the time of the activity. Please contact pharmce@uic.edu if you do not see activity information listed within 30 days. For more information and to set up your e-Profile visit: National Association of Boards of Pharmacy – CPE Monitor
Copyright © 2025– The Board of Trustees of the University of Illinois. All rights reserved. Reproduction in whole or in part without permission is prohibited. Privacy Policy